MASH

17 registered clinical trials studyying MASH — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants NCT07512427	OPKO Health, Inc.	Phase 1 / Phase 2
Not Yet Recruiting	Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity NCT07417683	Trans-Duodenal Concepts GmbH	N/A
Recruiting	Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine NCT07083557	Bettina Mittendorfer	—
Recruiting	Endoscopic Ultrasound Shear Wave Elastography Study NCT06592820	Olympus Corporation of the Americas	—
Recruiting	Incidence of Liver Disease-Related Outcomes in People With HIV NCT06940375	Shanghai Public Health Clinical Center	—
Recruiting	Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821	Pichamol Jirapinyo, MD, MPH	N/A
Recruiting	Digoxin In NASH (CODIN) NCT06588699	Yale University	Phase 2
Active Not Recruiting	Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects NCT06485245	Cascade Pharmaceuticals, Inc	Phase 1
Active Not Recruiting	A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH L NCT06903065	Hoffmann-La Roche	Phase 1
Withdrawn	A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis NCT06594523	Sagimet Biosciences Inc.	Phase 3
Withdrawn	A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH NCT06692283	Sagimet Biosciences Inc.	Phase 3
Completed	Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects NCT06573528	Cascade Pharmaceuticals, Inc	Phase 1
Recruiting	A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient NCT06562361	Antaros Medical	EARLY_Phase 1
Not Yet Recruiting	Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Ac NCT06446908	Hopital Montfort	N/A
Completed	ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) NCT06342947	Aligos Therapeutics	Phase 2
Recruiting	Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease NCT07051863	Fondazione Epatocentro Ticino	—
Recruiting	Global Research Initiative for Patients Screening on MASH NCT05651724	Julius Clinical	—